PSDV pSivida Corp.

1.77
+0  (2%)
Previous Close 1.74
Open 1.75
Price To book 4.03
Market Cap 60.49M
Shares 34,176,000
Volume 1,211,079
Short Ratio 1.90
Av. Daily Volume 224,290

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data released December 2015. Second Phase 3 trial data and NDA filing due 1H 2017.
Medidur
Posterior uveitis
CRL Nov 2011. Second CRL Oct 17 2013. Approved Sept 26 2014
Iluvien
Diabetic macular edema